UBE2D1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.861000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.485800E-01
Normal-vs-Stage2
4.171200E-01
Normal-vs-Stage3
1.456850E-01
Normal-vs-Stage4
7.028400E-01
Stage1-vs-Stage2
8.470600E-01
Stage1-vs-Stage3
6.027800E-01
Stage1-vs-Stage4
7.335200E-01
Stage2-vs-Stage3
3.747400E-01
Stage2-vs-Stage4
7.048600E-01
Stage3-vs-Stage4
4.455800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.448200E-01
Normal-vs-AfricanAmerican
7.063200E-01
Normal-vs-Asian
5.522800E-01
Caucasian-vs-AfricanAmerican
4.667200E-01
Caucasian-vs-Asian
7.050600E-01
AfricanAmerican-vs-Asian
7.529600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.628600E-01
Normal-vs-Female
3.096800E-01
Male-vs-Female
5.379200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.979600E-01
Normal-vs-Age(41-60Yrs)
8.640600E-01
Normal-vs-Age(61-80Yrs)
2.198800E-01
Normal-vs-Age(81-100Yrs)
1.604790E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.197400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.308800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.073800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.631900E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.012200E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.313400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.626230E-01
Normal-vs-Daily Drinker
3.569200E-01
Normal-vs-Weekly Drinker
8.309800E-02
Normal-vs-Occasional Drinker
7.953200E-01
Normal-vs-Social Drinker
2.176400E-01
Non Drinker-vs-Daily Drinker
7.092800E-01
Non Drinker-vs-Weekly Drinker
8.300800E-01
Non Drinker-vs-Occasional Drinker
4.977600E-02
Non Drinker-vs-Social Drinker
9.557200E-01
Daily Drinker-vs-Weekly Drinker
8.672600E-01
Daily Drinker-vs-Occasional Drinker
1.899970E-01
Daily Drinker-vs-Social Drinker
7.381600E-01
Weekly Drinker-vs-Occasional Drinker
1.136380E-01
Weekly Drinker-vs-Social Drinker
8.154200E-01
Occasional Drinker-vs-Social Drinker
1.100160E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.805600E-01
Normal-vs-Grade 2
8.182500E-02
Normal-vs-Grade 3
1.525000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.824010E-01
Grade 1-vs-Grade 3
3.064400E-01
Grade 1-vs-Grade 4
3.805600E-01
Grade 2-vs-Grade 3
6.942600E-01
Grade 2-vs-Grade 4
8.182500E-02
Grade 3-vs-Grade 4
1.525000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.993820E-01
Normal-vs-NonDiabetic
3.372000E-01
Diabetic-vs-NonDiabetic
4.231400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.149610E-02
Normal-vs-NoPancreatitis
3.762200E-01
Pancreatitis-vs-NoPancreatitis
7.878300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.690600E-01
Normal-vs-N1
4.247000E-01
N0-vs-N1
3.287400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.410400E-02
Normal-vs-TP53-NonMutant
2.185100E-04
TP53-Mutant-vs-TP53-NonMutant
1.637900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
